The effect of intravenous interferon-beta-1a (FP-1201) on lung CD73 expression and on acute respiratory distress syndrome mortality: an open-label study.

PubWeight™: 2.80^‹?› | Rank: Top 1%

🔗 View Article (PMID 24503265)

Published in Lancet Respir Med on December 23, 2013

Authors

Geoff Bellingan¹, Mikael Maksimow², David C Howell³, Martin Stotz⁴, Richard Beale⁵, Monika Beatty⁶, Timothy Walsh⁶, Alexander Binning⁷, Alan Davidson⁸, Martin Kuper⁹, Sanjoy Shah¹⁰, Jackie Cooper¹¹, Matti Waris¹², Gennady G Yegutkin¹³, Juho Jalkanen¹⁴, Marko Salmi¹⁵, Ilse Piippo², Markku Jalkanen², Hugh Montgomery¹⁶, Sirpa Jalkanen¹⁷

Author Affiliations

1: Critical Care, University College Hospital, London, UK; Department of Medicine, University College London and NIHR University College London Hospitals Biomedical Research Centre, UK.
2: Faron Pharmaceuticals, Turku, Finland.
3: Critical Care, University College Hospital, London, UK.
4: St Mary's Imperial College Hospital, London, UK.
5: St Thomas's Hospital, London, UK.
6: Royal Infirmary Edinburgh, UK.
7: Victoria Infirmary Glasgow, UK.
8: Western Infirmary Glasgow, UK.
9: Whittington Hospital London, UK.
10: Bristol Royal Infirmary, Bristol, UK.
11: Centre for Cardiovascular Genetics, Institute of Cardiovascular Science, University College London, UK.
12: Department of Virology, University of Turku, Finland.
13: MediCity Research Laboratory, University of Turku, Finland; Department of Medical Microbiology, University of Turku, Finland.
14: Department of Vascular Surgery, Turku University Hospital, Finland.
15: MediCity Research Laboratory, University of Turku, Finland; Department of Medical Biochemistry and Genetics, University of Turku, Finland.
16: Department of Medicine, University College London and NIHR University College London Hospitals Biomedical Research Centre, UK; Whittington Hospital London, UK.
17: MediCity Research Laboratory, University of Turku, Finland; Department of Medical Microbiology, University of Turku, Finland. Electronic address: sirpa.jalkanen@utu.fi.

Associated clinical trials:

Safety, Tolerability and Preliminary Efficacy of FP-1201 in ALI and ARDS. Phase I/II | NCT00789685

Articles citing this ↘

Use of interferon beta for acute respiratory distress syndrome: proceed with caution. Lancet Respir Med (2014) 1.07

Ectoenzymes in leukocyte migration and their therapeutic potential. Semin Immunopathol (2014) 0.90

Treating ARDS: new hope for a tough problem. Lancet Respir Med (2013) 0.80

Immunologic Consequences of Hypoxia during Critical Illness. Anesthesiology (2016) 0.79

Emerging therapies for the prevention of acute respiratory distress syndrome. Ther Adv Respir Dis (2015) 0.78

Hypoxia-induced inflammation and purinergic signaling in cross clamping the human aorta. Springerplus (2016) 0.77

Psychometric properties of Patient Reported Outcome Measures (PROMs) in patients diagnosed with Acute Respiratory Distress Syndrome (ARDS). Health Qual Life Outcomes (2016) 0.77

Human vascular progenitor cells derived from renal arteries are endothelial-like and assist in the repair of injured renal capillary networks. Kidney Int (2016) 0.77

Is there a need for emerging drugs for the acute respiratory distress syndrome? Expert Opin Emerg Drugs (2014) 0.76

Acute respiratory distress syndrome following cardiovascular surgery: current concepts and novel therapeutic approaches. Curr Opin Anaesthesiol (2016) 0.76

Soluble CD73 in Critically Ill Septic Patients - Data from the Prospective FINNAKI Study. PLoS One (2016) 0.75

Use of interferon beta for acute respiratory distress syndrome: proceed with caution--authors' reply. Lancet Respir Med (2014) 0.75

Complement and sepsis-induced heart dysfunction. Mol Immunol (2016) 0.75

Extremes of Interferon-Stimulated Gene Expression Associate with Worse Outcomes in the Acute Respiratory Distress Syndrome. PLoS One (2016) 0.75

Articles by these authors ⇆

Treatment of persistent rhinovirus infection with pegylated interferon α2a and ribavirin in patients with hypogammaglobulinemia. Clin Infect Dis (2014) 0.91

A randomised controlled trial and cost-effectiveness analysis of high-frequency oscillatory ventilation against conventional artificial ventilation for adults with acute respiratory distress syndrome. The OSCAR (OSCillation in ARDS) study. Health Technol Assess (2015) 0.89

Echovirus 30 meningitis epidemic followed by an outbreak-specific RT-qPCR. J Clin Virol (2015) 0.79

Use of interferon beta for acute respiratory distress syndrome: proceed with caution--authors' reply. Lancet Respir Med (2014) 0.75

Clinical and Socioeconomic Burden of Respiratory Syncytial Virus Infection in Children. J Infect Dis (2016) 0.75